VanEck Pharmaceutical ETF (PPH)

PPH Holdings Information

PPH is an equity ETF with a total of 24 individual holdings. The top holdings are Eli Lilly and Company stock at 17.31%, Johnson & Johnson at 11.55%, Novartis AG ADR at 7.88%, Merck & Co. at 6.25%, and Novo Nordisk at 6.10%.

• Total Holdings: 24
• Top 10 Percentage: 72.78%
• Asset Class: Equity
• ETF Category: Health
• Assets: 625.65M
• PE Ratio: 18.73

Top 25 Holdings

As of Sep 3, 2025

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	17.31%	147,539
2	JNJ	Johnson & Johnson	11.55%	406,672
3	NVSN.MX	Novartis AG ADR	7.88%	389,938
4	MRK	Merck & Co., Inc.	6.25%	457,927
5	NVO	Novo Nordisk A/S	6.10%	678,568
6	ABBV	AbbVie Inc.	5.06%	149,770
7	AZN	AstraZeneca PLC	4.98%	388,962
8	PFE	Pfizer Inc.	4.67%	1,171,651
9	SNY	Sanofi	4.57%	577,107
10	MCK	McKesson Corporation	4.41%	39,964
11	BMY	Bristol-Myers Squibb Company	4.33%	571,813
12	GSK	GSK plc	4.28%	689,141
13	ZTS	Zoetis Inc.	4.21%	172,452
14	COR	Cencora, Inc.	3.77%	80,235
15	HLN	Haleon plc	3.40%	2,186,213
16	TAK	Takeda Pharmaceutical Company Limited	2.89%	1,194,374
17	TEVA	Teva Pharmaceutical Industries Limited	1.76%	588,801
18	VTRS	Viatris Inc.	0.76%	453,507
19	JAZZ	Jazz Pharmaceuticals plc	0.56%	27,224
20	ELAN	Elanco Animal Health Incorporated	0.41%	145,297
21	AXSM	Axsome Therapeutics, Inc.	0.33%	16,589
22	PRGO	Perrigo Company plc	0.18%	47,810
23	OGN	Organon & Co.	0.16%	109,058
24	TSX: BHC	Bausch Health Companies Inc.	0.16%	133,190